Pfizer

Pfizer is a multinational pharmaceutical corporation that researches, develops, manufactures, and markets prescription medicines and vaccines.

Why it’s in the news: It is in the news due to its ongoing competition in the vaccine market, strategic partnerships, corporate restructuring, and financial performance.

Latest on Pfizer

• STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market
• VNVC, Pfizer expand cooperation to strengthen Vietnam's vaccine capabilities
• STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more
• STAT+: Pharmalittle: We’re reading about a Medicare pilot and orphan drugs, Pfizer cutbacks, and more
• Q1 Results Today Live: Hindustan Unilever shares fall 5% as Q1 profit dip, Indoco Remedies turn profitable, L&T, Ambuja Cements, Cholamandalam, Pfizer, Radico, Tata Capital, Suzlon, Supreme Ind, Netweb Tech to announce Q1 results
• STAT+: Pharmalittle: We’re reading about FDA reforming clinical trials, a Pfizer setback, and much more news
• [via BlackRock]
• [via The Vanguard Group]
• 13F: Pps&V Asset Management Consultants holds Pfizer ($342,749)
• Wikidata: Pfizer — located in — United States
• Wikidata: Pfizer — operates in — pharmaceutical industry
• Wikidata: Pfizer — capital ownership — Pfizer, spol. s r.o.

Connections

58 entities linked to Pfizer across the news graph.